Basic Information
Basic information for FTX-260-63aa
Peptide Name FTX-260-63aa
Genome Position chrX:74278777-74278965[-]
Species Human
Peptide Sequence MESHSNQLASEFLPTQIKLTQKAHSQIGLHIQKELCFICLTVVNSFILYVWFPHFFLLFRGNF
Peptide Length 63
Unique No (FTX-203-63aa,FTX-205-63aa,FTX-237-63aa,FTX-247-63aa,FTX-248-63aa,FTX-252-63aa,FTX-263-63aa,FTX-267-63aa)
Grand Average of Hydropathicity 0.3556
Relative Molecular Mass 8529.71
Experimental Evidences no
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000662864;FTX-260
Transcript Length 2838
Coding Ability 0.4084
DNA Sequence Corresponding to Peptide ATGGAATCTCATAGTAATCAGCTTGCTTCTGAATTTCTTCCCACTCAAATTAAGCTCACTCAGAAAGCACATTCACAAATTGGGCTACATATACAGAAGGAGCTATGTTTTATATGCCTCACTGTAGTCAACTCATTTATCCTATATGTATGGTTCCCCCATTTTTTCCTTCTTTTCAGGGGTAACTTT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :